U.S. federal trademark · Serial No. 97695772
Research and development with RNA editing technology. We deliver edit-to-cure therapeutics for undruggable target conditions by using RNA-editing to address the root cause of disease progression
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.